Q1 FY27 saw resilient sugar and biofuels performance despite weather and pricing headwinds, while value-added consumer products and nutraceuticals drove margin expansion. Cash fixed costs fell 11% and free cash flow was positive. PSRIPL refinery closure and new product launches marked key developments.
